Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression

Archive ouverte

Nicolle, Rémy | Ayadi, Mira | Gomez-Brouchet, Anne | Armenoult, Lucile | Banneau, Guillaume | Elarouci, Nabila | Tallegas, Matthias | Decouvelaere, Anne-Valérie | Aubert, Sébastien | Rédini, Françoise | Marie, Béatrice | Labit-Bouvier, Corinne | Reina, Nicolas | Karanian, Marie | Le Nail, Louis-Romée | Anract, Philippe | Gouin, François | Larousserie, Frédérique | de Reyniès, Aurélien | de Pinieux, Gonzague

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract Chondrosarcomas are primary cancers of cartilaginous tissue with highly contrasting prognoses. These tumors are defined by recurrent mutations in the IDH genes and other genetic alterations including inactivation of CDKN2A and COL2A1 ; however, these have no clinical value. Here we use multi-omics molecular profiles from a series of cartilage tumors and find an mRNA classification that identifies two subtypes of chondrosarcomas defined by a balance in tumor differentiation and cell cycle activation. The microRNA classification reveals the importance of the loss of expression of the 14q32 locus in defining the level of malignancy. Finally, DNA methylation is associated with IDH mutations. We can use the multi-omics classifications to predict outcome. We propose an mRNA-only classifier to reproduce the integrated multi-omics classification, and its application to relapsed tumor samples shows the progressive nature of the classification. Thus, it may be possible to use mRNA-based signatures to detect patients with high-risk chondrosarcomas.

Consulter en ligne

Suggestions

Du même auteur

Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS)

Archive ouverte | Gomez-Brouchet, Anne | CCSD

International audience. Osteosarcoma, the most common bone malignancy with a peak incidence at adolescence, had no survival improvement since decades. Persistent problems are chemo-resistance and metastatic spread. ...

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Archive ouverte | Gomez-Brouchet, Anne | CCSD

International audience. The French phase 3 trial (OS 2006) testing zoledronic acid, an osteoclast inhibitor, with chemotherapy and surgery did not improve the outcome of patients with osteosarcoma (OS). To understan...

Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples

Archive ouverte | Miquelestorena-Standley, Elodie | CCSD

International audience. Biological and histopathological techniques identified osteoclasts and macrophages as targets of zoledronic acid (ZA), a therapeutic agent that was detrimental for patients in the French OS20...

Chargement des enrichissements...